Michael Cheetham

Michael Cheetham

Auto-generated profile, based on publicly available information

Michael Cheetham

Office of Portfolio Analysis, U.S. National Institutes of Health, Bethesda, Maryland

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in The Lancet Global Health
Verified
Journal Article
Open access
TATaghreed Adam
Taghreed Adam
HAHannah Akuffo
Hannah Akuffo
JCJames G Carter
James G Carter
ZCZach Charat
Zach Charat
MCMichael J Cheetham
Michael J Cheetham
RGRoger I Glass
Roger I Glass

2 June 2023 in Annals of Global Health
Verified
Journal Article
Open access
PDF file
PKPeter H. Kilmarx
Peter H. Kilmarx
TMThabi Maitin
Thabi Maitin
TATaghreed Adam
Taghreed Adam
GAGarry Aslanyan
Garry Aslanyan
MCMichael Cheetham
Michael Cheetham
SSSoumya Swaminathan
Soumya Swaminathan
Background: The ESSENCE on Health Research initiative established a Working Group on Review of Investments in 2018 to improve coordination and collaboration among funders of health research capacity strengthening. The Working Group comprises more than a dozen ESSENCE members, including diverse representation by geography, country income level, the public sector, and philanthropy. Objective: The overall goal of the Working Group is increased research on national health priorities as well as improved pandemic preparedness, and, ultimately, fewer countries with very limited research capacity. Methods: We developed a basic set of metrics for national health research capacity, assessed different models of coordination and collaboration, took a deeper dive into eight countries to characterize their national research capacity, and began to identify opportunities to better coordinate our investments. In this article, we summarize the presentations, discussions, and outcomes of our second annual (virtual) meeting, which had more than 100 participants representing funders, researchers, and other stakeholders from higher- and lower-income countries worldwide. Findings and conclusions: Presentations on the first day included the keynote speaker, Dr. Soumya Swaminathan, chief scientist of the World Health Organization (WHO), and updates on data and metrics for research capacity, which are critical to establish targets, road maps, and budgets. The second day focused on improving collaboration and coordination among funders and other stakeholders, the potential return on investment for health research, ongoing work to increase coordination at the country level, and examples of research capacity strengthening efforts in diverse health research areas from around the world. We concluded that an intentional data- and metric-driven approach to health research capacity strengthening, emphasizing coordination among funders, local leadership, and equitable partnerships and allocation of resources, will enhance the health systems of resource-poor countries as well as the world’s pandemic preparedness.